CD8A and neoplasm: It has been previously reported that B-cell-derived GABA could affect the classification of macrophages and inhibit anti-tumor immunity, and another study found that GABA secreted by tumor cells were to activate GSK3 β-Pathway to inhibit CD8+T cell-mediated tumor immunity [11, 12].